Malignant Neoplasm of Stomach Terminated Phase 2 Trials for Bortezomib (DB00188)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00103103Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach CancerTreatment